High Tech Pharm Co., Ltd.

KOSDAQ:A106190 Stock Report

Market Cap: ₩168.0b

High Tech Pharm Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Jeong-Soo Kim

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership2.6%
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

Analysis Article Feb 10

High Tech Pharm Co., Ltd. (KOSDAQ:106190) Stock Rockets 36% But Many Are Still Ignoring The Company

High Tech Pharm Co., Ltd. ( KOSDAQ:106190 ) shareholders would be excited to see that the share price has had a great...
Analysis Article Sep 02

Investor Optimism Abounds High Tech Pharm Co., Ltd. (KOSDAQ:106190) But Growth Is Lacking

It's not a stretch to say that High Tech Pharm Co., Ltd.'s ( KOSDAQ:106190 ) price-to-earnings (or "P/E") ratio of...
Analysis Article Jun 11

We Think High Tech Pharm (KOSDAQ:106190) Can Stay On Top Of Its Debt

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article Oct 23

A Look At The Intrinsic Value Of High Tech Pharm Co., Ltd. (KOSDAQ:106190)

Key Insights Using the 2 Stage Free Cash Flow to Equity, High Tech Pharm fair value estimate is ₩16,394 With ₩15,600...
Analysis Article Aug 06

Is High Tech Pharm (KOSDAQ:106190) Using Too Much Debt?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article Jul 02

Subdued Growth No Barrier To High Tech Pharm Co., Ltd. (KOSDAQ:106190) With Shares Advancing 25%

High Tech Pharm Co., Ltd. ( KOSDAQ:106190 ) shares have continued their recent momentum with a 25% gain in the last...
Analysis Article May 09

There's Reason For Concern Over High Tech Pharm Co., Ltd.'s (KOSDAQ:106190) Massive 25% Price Jump

High Tech Pharm Co., Ltd. ( KOSDAQ:106190 ) shares have continued their recent momentum with a 25% gain in the last...
Analysis Article Apr 23

Is High Tech Pharm (KOSDAQ:106190) A Risky Investment?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article Feb 23

We Think High Tech Pharm (KOSDAQ:106190) Has A Fair Chunk Of Debt

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analysis Article Jan 19

Did High Tech Pharm's (KOSDAQ:106190) Share Price Deserve to Gain 91%?

These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But one can do...
Analysis Article Dec 15

What Is The Ownership Structure Like For High Tech Pharm Co., Ltd. (KOSDAQ:106190)?

The big shareholder groups in High Tech Pharm Co., Ltd. ( KOSDAQ:106190 ) have power over the company. Large companies...

CEO

Jeong-Soo Kim (67 yo)

no data
Tenure

Mr. Jeong-Soo Kim serves as the Chief Executive Officer of HIGH TECH PHARM CO.,LTD.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/24 05:40
End of Day Share Price 2026/05/22 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

High Tech Pharm Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.